Drawing for SEEK

USPTO serial 79100334

SEEK

Reviewed by CopyMark Law Group

Reg. 4107395Status 404
Filing date
Status date
Registration date
Mar 6, 2012
Examiner
ORNDORFF, LINDA
Law office
PUBLICATION AND ISSUE SECTION

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with SEEK?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Goods and services

ClassDescriptionStatusFirst use
005Pharmaceutical preparations for use in the treatment of influenza, HIV, hepatitis C, hepatitis B, mosquito borne diseases, tuberculosis, rheumatoid arthritis, rotavirus, blood disorders, cancer, cardiovascular diseases, central nervous system diseases and disorders, diabetes, endocrine disorders, gastrointestinal disorders, hormonal diseases and disorders, inflammation and inflammatory disorders, musculoskeletal disorders, neurodegenerative disorders, neurological disorders, obesity, ophthalmologic conditions and disorders, sexual dysfunction, urological disorders, viral, protozoa and bacterial disorders, diseases and illnesses; veterinary preparations, namely, amino acids for veterinary purposes, anti-infective products for veterinary use, bacterial preparations for veterinary purposes, biochemical preparations for use in the treatment of influenza, HIV, hepatitis C, hepatitis B, mosquito borne diseases, tuberculosis, rheumatoid arthritis, rotavirus, blood disorders, cancer, cardiovascular diseases, central nervous system diseases and disorders, diabetes, endocrine disorders, gastrointestinal disorders, hormonal diseases and disorders, inflammation and inflammatory disorders, musculoskeletal disorders, neurodegenerative disorders, neurological disorders, obesity, ophthalmologic conditions and disorders, sexual dysfunction, urological disorders, viral, protozoa and bacterial disorders, diseases and illnesses, blood substitute for veterinary use, veterinary vaccines, pain relief medication for veterinary use, veterinary preparations for the treatment of intestinal bacteria, veterinary parasiticides for livestock use; sanitary sterilizing preparations; dietetic substances, namely, foods adapted for medical use; medical plasters, disinfectants for medical instruments and sanitary purposes, fungicides, herbicides, preparations for destroying vermin, pain relief medications; nutritional substances, namely, nutritional substances in the nature of capsules containing glucosamine and chondroitin and nutritional supplements, vitamins, mineral supplements, and nutritional supplements, namely, glucosamine and chondroitin; nutraceuticals for use as a dietary supplement, nutritional substances, namely, intravenous fluids used for nutrition; food supplements for medical purposes, dietetic beverages and dietetic foods adapted for medical use; medical use and nutritional supplements, vitamins, mineral supplements, bacteriological preparations for medical or veterinary purposes; biological preparations for the treatment of influenza, HIV, hepatitis C, hepatitis B, mosquito borne diseases, tuberculosis, rheumatoid arthritis, rotavirus, blood disorders, cancer, cardiovascular diseases, central nervous system diseases and disorders, diabetes, endocrine disorders, gastrointestinal disorders, hormonal diseases and disorders, inflammation and inflammatory disorders, musculoskeletal disorders, neurodegenerative disorders, neurological disorders, obesity, ophthalmologic conditions and disorders, sexual dysfunction, urological disorders, viral, protozoa and bacterial disorders, diseases and illnesses, diagnostic preparations for medical purposes, chemicals for use in the manufacture of pharmaceuticals; vaccinesSECTION 71 - CANCELLED—
044Medical services, veterinary services, hygienic care for human beings; medical clinics, convalescent home services, dentistry, healthcare services, nursing homes, midwife services, opticians services, physiotherapy services, psychology services, blood bank services, agricultural services, namely, agricultural advice, spreading of fertilizers and other agricultural chemicals; horticultural services; forestry services, namely, providing advice pertaining to pest control for forestry; hospice, hospital, medical assistance, nursing services, pharmaceutical advice, and rest home services; surgery, assistance and advice in the fields of sanitary, nutritional, naturopathic, allopathic, pharmaceutical, medical and healthcare products and services; information and advisory services relating to the foregoing; including the provision of such services via the Internet, by online means and/or by communications networks, provision of information relating to pharmaceuticals, drug delivery systems, vaccinesSECTION 71 - CANCELLED—
045Licensing of intellectual property; licensing of technologies in relation to medical and scientific research; regulatory compliance consulting in the field of pharmaceuticals and pharmaceutical compounds; official regulatory assistance and advice in the fields of chemical, sanitary, food, beverage, nutritional, naturopathic, pharmaceutical, medical, veterinary and healthcare products and servicesSECTION 71 - CANCELLED—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Oct 10, 2021DENCNOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG MAILED—
Oct 10, 2021DETHDEATH OF INTERNATIONAL REGISTRATION—
Nov 30, 2019INNTTOTAL INVALIDATION PROCESSED BY THE IB—
Jun 29, 2019INTSTOTAL INVALIDATION OF REG EXT PROTECTION SENT TO IB—
Jun 29, 2019INPCINVALIDATION PROCESSED—
Jun 12, 2019INTRTOTAL INVALIDATION OF REG EXT PROTECTION CREATED—
Mar 14, 2019NREPNEW REPRESENTATIVE AT IB RECEIVED—
Feb 21, 2019NREPNEW REPRESENTATIVE AT IB RECEIVED—
Oct 12, 2018C71TCANCELLED SECTION 71—
Oct 25, 2012GPNXNOTIFICATION PROCESSED BY IB—
Aug 4, 2012FINOFINAL DECISION TRANSACTION PROCESSED BY IB—
Jul 13, 2012FICSFINAL DISPOSITION NOTICE SENT TO IB—
Jul 13, 2012FIMPFINAL DISPOSITION PROCESSED—
Jun 6, 2012FICRFINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB—
Mar 6, 2012R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Dec 20, 2011PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Nov 30, 2011OPNSNOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB—
Nov 30, 2011OP2RNOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB—
Nov 30, 2011NPUBNOTICE OF PUBLICATION—
Nov 15, 2011PREVLAW OFFICE PUBLICATION REVIEW COMPLETED—
Nov 15, 2011ALIEASSIGNED TO LIE—
Oct 25, 2011CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Oct 21, 2011TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Oct 21, 2011CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Oct 21, 2011TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Oct 17, 2011CNRTNON-FINAL ACTION MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Oct 17, 2011CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Sep 23, 2011TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Sep 23, 2011CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Sep 23, 2011TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Sep 11, 2011RFNTREFUSAL PROCESSED BY IB—
Aug 24, 2011RFCSNON-FINAL ACTION MAILED - REFUSAL SENT TO IB—
Aug 24, 2011RFRRREFUSAL PROCESSED BY MPU—
Aug 24, 2011RFCRNON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW—
Aug 23, 2011CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Aug 16, 2011MAFRAPPLICATION FILING RECEIPT MAILED—
Aug 12, 2011DOCKASSIGNED TO EXAMINER—
Aug 12, 2011NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Aug 11, 2011REPRSN ASSIGNED FOR SECT 66A APPL FROM IB—

Frequently asked questions

Related guidance